fbpx
Medical Innovation Exchange

Biogen bets more than $700M on Alectos’ preclinical oral Parkinson’s drug to shore up pipeline

https://www.fiercebiotech.com/biotech/biogen-shoring-back-its-pipeline-bets-more-700m-alectos-preclinical-oral-parkinsons-med

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.